Text Size

Cardiac Tumors in Children

This study has been terminated.
(insufficient data)
Sponsor:
Information provided by:
Children's Healthcare of Atlanta
ClinicalTrials.gov Identifier:
NCT00215085
First received: September 20, 2005
Last updated: March 14, 2012
Last verified: May 2007
History of Changes
  Purpose

The purpose of this study is to define the natural history of untreated cardiac tumors, study the pathology of primary cardiac tumors, review the surgical treatment and results of primary cardiac tumors and to determine the prognosis for these tumors.


Condition
Congenital Heart Disease

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Cardiac Tumors in Children

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Children's Healthcare of Atlanta:

Estimated Enrollment: 70
Study Start Date: May 2005
Study Completion Date: November 2006
Detailed Description:

Primary cardiac tumors in children are extremely rare. Benign tumors are typically myxomas, lipomas, and rhabdomyomas, while malignant tumors are typically angiosarcomas and rhabdomyosarcomas. Due to the rarity of these tumors, it is difficult to gather meaningful information regarding their natural history, pathology and treatment.

The primary aims are to define the natural history of untreated cardiac tumors, study the pathology of primary cardiac tumors, review the surgical treatment and results of primary cardiac tumors and to determine the prognosis for these tumors. The secondary aims are to discover patterns and consistencies among primary cardiac tumors and to define the best treatment options for these patients. The study will be conducted through a retrospective chart review of about 70 patients.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients in the congenital surgery database

  • Children who have been treated for a primary cardiac tumor
Criteria

Inclusion Criteria:

  • Patients in the congenital surgery database
  • Children who have been treated for a primary cardiac tumor
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00215085

Locations
United States, Georgia
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Children's Healthcare of Atlanta
Investigators
Principal Investigator: Brian Kogon, MD Emory University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00215085     History of Changes
Other Study ID Numbers: 05-091
Study First Received: September 20, 2005
Last Updated: March 14, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Healthcare of Atlanta:
pediatric health
cardiac
cardiac tumor
children

Additional relevant MeSH terms:
Heart Diseases
Heart Neoplasms
Heart Defects, Congenital
Cardiovascular Diseases
Thoracic Neoplasms
 Neoplasms by Site
Neoplasms
Cardiovascular Abnormalities
Congenital Abnormalities

ClinicalTrials.gov processed this record on May 19, 2013